Tepotinib 225 mg Tablets – Uses, Benefits, Dosage, Side Effects & FAQs

Tepotinib 225 mg Tablets

Tepotinib 225 mg Tablets are a targeted anticancer medication used for the treatment of non-small cell lung cancer (NSCLC) in patients whose tumors have a MET exon 14 skipping alteration. Tepotinib belongs to the class of MET kinase inhibitors, which specifically target cancer cells while helping minimize damage to healthy cells.

This precision medicine is prescribed after molecular testing confirms the presence of the MET exon 14 mutation, making it an effective treatment option for eligible patients.

What is Tepotinib 225 mg?

Tepotinib is an oral tyrosine kinase inhibitor (TKI) that blocks the activity of the MET receptor. Abnormal activation of the MET pathway can cause cancer cells to grow, spread, and survive. By inhibiting this pathway, Tepotinib helps slow or stop the progression of cancer.

Uses of Tepotinib 225 mg Tablets

Tepotinib 225 mg Tablets are primarily indicated for:

Treatment of metastatic non-small cell lung cancer (NSCLC)

Patients with MET exon 14 skipping mutations confirmed through an approved diagnostic test

Advanced or recurrent NSCLC where targeted therapy is appropriate

Your oncologist will determine whether Tepotinib is suitable based on your cancer type and genetic test results.

How Tepotinib Works

Tepotinib selectively inhibits the MET receptor tyrosine kinase, preventing abnormal signaling responsible for:

Tumor cell growth

Cancer cell survival

Tumor invasion

Metastasis

This targeted mechanism helps improve treatment outcomes in patients with MET-driven lung cancer.

Dosage & Administration

Typical adult dosage: 450 mg once daily (commonly administered as two 225 mg tablets).

Take with food at approximately the same time every day.

Swallow tablets whole with water.

Do not crush, split, or chew the tablets.

Continue treatment as directed by your oncologist until disease progression or unacceptable toxicity occurs.

Always follow your healthcare provider's instructions.

Benefits of Tepotinib 225 mg Tablets

Targeted treatment for MET-positive NSCLC

Helps slow cancer progression

Convenient oral tablet taken once daily

Precision medicine based on genetic testing

May improve progression-free survival in eligible patients

Possible Side Effects

Like all medications, Tepotinib may cause side effects.

Common side effects include:

Swelling (edema)

Fatigue

Nausea

Diarrhea

Decreased appetite

Muscle pain

Increased liver enzymes

Serious side effects may include:

Interstitial lung disease (ILD)

Severe liver toxicity

Breathing difficulties

Serious allergic reactions

Contact your healthcare provider immediately if you experience severe or unusual symptoms.

Precautions

Before taking Tepotinib, inform your doctor if you:

Have liver disease

Have kidney problems

Have lung disease

Are pregnant or planning pregnancy

Are breastfeeding

Take prescription medicines, supplements, or herbal products

Regular blood tests may be required to monitor liver function during treatment.

Drug Interactions

Tepotinib may interact with:

Strong CYP inhibitors or inducers

Certain antibiotics

Antifungal medications

Herbal supplements

Other anticancer therapies

Discuss all medications with your healthcare provider before starting treatment.

Storage Instructions

Store at room temperature.

Keep away from moisture and direct sunlight.

Store in the original packaging.

Keep out of reach of children.

Frequently Asked Questions (FAQs)

1. What is Tepotinib 225 mg Tablet used for?

Tepotinib is used to treat metastatic non-small cell lung cancer (NSCLC) with a confirmed MET exon 14 skipping mutation.

2. How should I take Tepotinib?

Take the prescribed dose once daily with food at the same time each day. Swallow the tablets whole.

3. Can I take Tepotinib without food?

No. Tepotinib should be taken with food to help ensure proper absorption.

4. What should I do if I miss a dose?

Take the missed dose as soon as you remember on the same day. If it is almost time for the next scheduled dose, skip the missed dose and continue your regular schedule. Do not take a double dose.

5. What are the most common side effects?

Common side effects include swelling, fatigue, nausea, diarrhea, decreased appetite, and elevated liver enzymes.

6. Is genetic testing required before using Tepotinib?

Yes. Treatment is recommended only after confirming a MET exon 14 skipping alteration through an approved diagnostic test.

7. Can pregnant women take Tepotinib?

No. Tepotinib may harm an unborn baby. Effective contraception should be used during treatment and for the period recommended by your healthcare provider after the last dose.

8. Can I drink alcohol while taking Tepotinib?

Alcohol may increase the risk of liver-related side effects. Consult your healthcare provider before consuming alcohol.

9. How long do I need to take Tepotinib?

Treatment continues until the disease progresses, unacceptable side effects occur, or your oncologist advises stopping therapy.